Adalimumab – March 2024

Adalimumab (uveitis): Injection 20 mg in 0.2 mL pre filled syringe, Injection 40 mg in 0.4 mL pre filled syringe, Injection 40 mg in 0.4 mL pre filled pen, Injection 80 mg 0.8 mL pre filled syringe, Injection 80 mg in 0.8 mL pre filled pen; Humira®